Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | O-6-methylguanine-DNA methyltransferase | Starlite/ChEMBL | References |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.2 uM | O6-Alkylguanine-DNA Alkyltransferase-Inactivating Activity in Raji cells (Concentration of inactivator required to produce 50% reduction in ATPase activity) | ChEMBL. | 9857094 |
IC50 (binding) | = 0.2 uM | O6-Alkylguanine-DNA Alkyltransferase-Inactivating Activity in Raji cells (Concentration of inactivator required to produce 50% reduction in ATPase activity) | ChEMBL. | 9857094 |
IC50 (binding) | = 0.25 uM | O6-Alkylguanine-DNA Alkyltransferase-Inactivating Activity (Concentration of inactivator required to produce 50% reduction in ATPase activity) | ChEMBL. | 9857094 |
IC50 (binding) | = 0.25 uM | O6-Alkylguanine-DNA Alkyltransferase-Inactivating Activity (Concentration of inactivator required to produce 50% reduction in ATPase activity) | ChEMBL. | 9857094 |
T1/2 (ADMET) | > 48 hr | In vitro half-life of the compound at 37 degree centigrade in phosphate-buffered saline(PBS; pH =7-7.2) | ChEMBL. | 9857094 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.